193 related articles for article (PubMed ID: 36991376)
21. Tumor antigen-specific CD8
Lu X; Yang L; Yao D; Wu X; Li J; Liu X; Deng L; Huang C; Wang Y; Li D; Liu J
Cell Immunol; 2017 Mar; 313():43-51. PubMed ID: 28110884
[TBL] [Abstract][Full Text] [Related]
22. Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma.
Mosayebian A; Koohini Z; Hossein-Nataj H; Abediankenari S; Abedi S; Asgarian-Omran H
Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):517-525. PubMed ID: 30644695
[TBL] [Abstract][Full Text] [Related]
23. High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.
Song L; Wang Y; Sui Y; Sun J; Li D; Li G; Liu J; Li T; Shu Q
Med Sci Monit; 2018 Aug; 24():5660-5667. PubMed ID: 30106887
[TBL] [Abstract][Full Text] [Related]
24. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.
Wang S; Zhu X; Xu Y; Zhang D; Li Y; Tao Y; Piao H; Li D; Du M
Hum Reprod; 2016 Apr; 31(4):700-11. PubMed ID: 26908841
[TBL] [Abstract][Full Text] [Related]
25. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
[TBL] [Abstract][Full Text] [Related]
26. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
27. The expression of Tim-3 in peripheral blood of ovarian cancer.
Wu J; Liu C; Qian S; Hou H
DNA Cell Biol; 2013 Nov; 32(11):648-53. PubMed ID: 24007284
[TBL] [Abstract][Full Text] [Related]
28. TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas.
Li Z; Liu X; Guo R; Wang P
Tumour Biol; 2017 May; 39(5):1010428317698352. PubMed ID: 28475007
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of tumor-reactive CD4
Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36581331
[TBL] [Abstract][Full Text] [Related]
30. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.
Lu BY; Gupta R; Aguirre-Ducler A; Gianino N; Wyatt H; Ribeiro M; Chiang VL; Contessa JN; Adeniran AJ; Jilaveanu LB; Kluger HM; Schalper KA; Goldberg SB
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670827
[TBL] [Abstract][Full Text] [Related]
31. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.
Tan J; Yu Z; Huang J; Chen Y; Huang S; Yao D; Xu L; Lu Y; Chen S; Li Y
Biomark Res; 2020; 8():6. PubMed ID: 32082573
[TBL] [Abstract][Full Text] [Related]
32. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.
Shahbazi M; Moulana Z; Sepidarkish M; Bagherzadeh M; Rezanejad M; Mirzakhani M; Jafari M; Mohammadnia-Afrouzi M
Microb Pathog; 2021 Apr; 153():104779. PubMed ID: 33548481
[TBL] [Abstract][Full Text] [Related]
33. Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8
Rezazadeh H; Astaneh M; Tehrani M; Hossein-Nataj H; Zaboli E; Shekarriz R; Asgarian-Omran H
Immunol Res; 2020 Oct; 68(5):269-279. PubMed ID: 32710227
[TBL] [Abstract][Full Text] [Related]
34. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
Qiu MK; Wang SC; Dai YX; Wang SQ; Ou JM; Quan ZW
PLoS One; 2015; 10(6):e0128523. PubMed ID: 26035207
[TBL] [Abstract][Full Text] [Related]
35. Highly proliferative and functional PD-1
Batorov EV; Aristova TA; Pronkina NV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Shevela EY; Ostanin AA; Chernykh ER
Int Immunopharmacol; 2021 Nov; 100():108093. PubMed ID: 34474273
[TBL] [Abstract][Full Text] [Related]
36. Tim-3 and PD-1 regulate CD8
Xu YY; Wang SC; Lin YK; Li DJ; DU MR
J Reprod Dev; 2017 Jun; 63(3):289-294. PubMed ID: 28331165
[TBL] [Abstract][Full Text] [Related]
37. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
38. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
[TBL] [Abstract][Full Text] [Related]
39. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy.
Wang SC; Li YH; Piao HL; Hong XW; Zhang D; Xu YY; Tao Y; Wang Y; Yuan MM; Li DJ; Du MR
Cell Death Dis; 2015 May; 6(5):e1738. PubMed ID: 25950468
[TBL] [Abstract][Full Text] [Related]
40. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
